Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis.

https://read.qxmd.com/read/39809902/safety-and-efficacy-of-the-rock-2-inhibitor-belumosudil-in-cgvhd-treatment-a-retrospective-german-swiss-multicenter-real-world-data-analysis?uac=148436CN&ecd=wnl_readmost_250207&sso=true&redirected=slug Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis. Belumosudil is a first in class ROCK2-inhibitor approved by the FDA for the 3rd line treatment of chronic graft-versus-host disease (cGvHD). In this retrospecti.. Jan 14, 2025: Bone Marrow Transplantation